Biocon Ltd - Stock Price

As on3 Dec 2021
  • BSE : 532523
  • ISIN CODE : INE376G01013
  • Industry : Pharmaceuticals & Drugs
  • House : Private
Biocon Ltd is not traded on BSE/NSE
-0.18 %-0.65
-0.12 %-0.45

Balance Sheet

Parameter MAR 21  MAR 20  YoY %Change
Share Capital6000.006000.000.00
    Equity - Authorised6250.006000.004.17
    Equity - Issued6000.006000.000.00
    Equity Paid Up6000.006000.000.00
    Equity Shares Forfeited0.000.000.00
    Adjustments to Equity0.000.000.00
    Preference Capital Paid Up0.000.000.00
    Face Value5.005.000.00
Share Warrants & Outstandings1541.001088.0041.64
Total Reserves68728.0059970.0014.60
    Securities Premium619.00238.00160.08
    Capital Reserves801.00801.000.00
    Profit & Loss Account Balance62358.0059141.005.44
    General Reserves1617.001617.000.00
    Other Reserves3333.00-1827.00282.43
Reserve excluding Revaluation Reserve68719.0059961.0014.61
Revaluation reserve9.009.000.00
Shareholder's Funds76269.0067058.0013.74
Minority Interest8807.006773.0030.03
Long-Term Borrowings0.000.000.00
Secured Loans14924.0012208.0022.25
    Non Convertible Debentures2000.000.000.00
    Converible Debentures & Bonds0.000.000.00
    Packing Credit - Bank0.000.000.00
    Inter Corporate & Security Deposit0.000.000.00
    Term Loans - Banks20952.0019564.007.09
    Term Loans - Institutions0.000.000.00
    Other Secured-8028.00-7356.00-9.14
Unsecured Loans14692.0014.00104842.86
    Fixed Deposits - Public0.000.000.00
    Loans and advances from subsidiaries0.000.000.00
    Inter Corporate Deposits (Unsecured)
    Foreign Currency Convertible Notes0.000.000.00
    Long Term Loan in Foreign Currency0.000.000.00
    Loans - Banks4392.000.000.00
    Loans - Govt.7.0014.00-50.00
    Loans - Others0.000.000.00
    Other Unsecured Loan10293.000.000.00
Deferred Tax Assets / Liabilities-2754.00-3382.0018.57
    Deferred Tax Assets4968.005187.00-4.22
    Deferred Tax Liability2214.001805.0022.66
Other Long Term Liabilities27045.0017149.0057.71
Long Term Trade Payables0.000.000.00
Long Term Provisions1062.00858.0023.78
Total Non-Current Liabilities54969.0026847.00104.75
Current LiabilitiesNANANA
Trade Payables15139.0013251.0014.25
    Sundry Creditors15139.0013251.0014.25
    Due to Subsidiaries- Trade Payables0.000.000.00
Other Current Liabilities18402.0017844.003.13
    Bank Overdraft / Short term credit95.00177.00-46.33
    Advances received from customers4006.003217.0024.53
    Interest Accrued But Not Due125.0014.00792.86
    Share Application Money0.000.000.00
    Current maturity of Debentures & Bonds0.000.000.00
    Current maturity - Others0.000.000.00
    Other Liabilities14176.0014436.00-1.80
Short Term Borrowings5942.006676.00-10.99
    Secured ST Loans repayable on Demands0.00854.00-100.00
    Working Capital Loans- Sec0.00854.00-100.00
    Buyers Credits - Unsec0.000.000.00
    Commercial Borrowings- Unsec0.000.000.00
    Other Unsecured Loans5942.004968.0019.61
Short Term Provisions2618.002309.0013.38
    Proposed Equity Dividend0.000.000.00
    Provision for Corporate Dividend Tax0.000.000.00
    Provision for Tax1524.001279.0019.16
    Provision for post retirement benefits0.000.000.00
    Preference Dividend0.000.000.00
    Other Provisions1094.001030.006.21
Total Current Liabilities42101.0040080.005.04
Total Liabilities182146.00140758.0029.40
Gross Block102209.0091474.0011.74
Less: Accumulated Depreciation38570.0031763.0021.43
Less: Impairment of Assets0.000.000.00
Net Block63639.0059711.006.58
Lease Adjustment A/c0.000.000.00
Capital Work in Progress22535.0015765.0042.94
Non Current Investments7432.001085.00584.98
Long Term Investment7432.001085.00584.98
Long Term Loans & Advances4364.004020.008.56
Other Non Current Assets2705.00732.00269.54
Total Non-Current Assets106142.0087508.0021.29
Current Assets Loans & AdvancesNANANA
Currents Investments12087.008576.0040.94
    Raw Materials4495.003111.0044.49
    Work-in Progress7349.003207.00129.15
    Finished Goods4289.005071.00-15.42
    Packing Materials2029.001618.0025.40
    Stores  and Spare0.000.000.00
    Other Inventory504.001352.00-62.72
Sundry Debtors12176.0012237.00-0.50
    Debtors more than Six months0.000.000.00
    Debtors Others12299.0012360.00-0.49
Cash and Bank20154.009986.00101.82
    Cash in hand0.000.000.00
    Balances at Bank20154.009986.00101.82
    Other cash and bank balances0.000.000.00
Other Current Assets10052.005436.0084.92
    Interest accrued on Investments0.000.000.00
    Interest accrued on Debentures0.000.000.00
    Deposits with Government0.000.000.00
    Interest accrued and or due on loans270.00129.00109.30
    Prepaid Expenses705.00689.002.32
    Other current_assets9077.004618.0096.56
Short Term Loans and Advances2869.002656.008.02
    Advances recoverable in cash or in kind667.00824.00-19.05
    Advance income tax and TDS0.000.000.00
    Amounts due from directors0.000.000.00
    Due From Subsidiaries0.000.000.00
    Inter corporate deposits0.000.000.00
    Corporate Deposits0.000.000.00
    Other Loans & Advances2202.001832.0020.20
Total Current Assets76004.0053250.0042.73
Net Current Assets (Including Current Investments)33903.0013170.00157.43
Miscellaneous Expenses not written off0.000.000.00
Total Assets182146.00140758.0029.40
Contingent Liabilities7150.007170.00-0.28
Total Debt43586.0026254.0066.02
Book Value62.2754.9713.28
Adjusted Book Value62.2754.9713.28

About Biocon Ltd.

Biocon Ltd. was incorporated in the year 1978. Its today's share price is 366.8. Its current market capitalisation stands at Rs 44038.01 Cr. In the latest quarter, company has reported Gross Sales of Rs. 20284 Cr and Total Income of Rs.21799 Cr. The company's management includes Mayank Verma, Mary Harney, Daniel Mark Bradbury, Vijay Kumar Kuchroo, Bobby Kanubhai Parikh, Meleveetil Damodaran, Ravi Mazumdar, Siddharth Mittal, Kiran Mazumdar-Shaw.

It is listed on the BSE with a BSE Code of 532523 , NSE with an NSE Symbol of BIOCON and ISIN of INE376G01013. It's Registered office is at 20th Km,Hosur Road,Electronic CityBengaluru-560100, Karnataka. Their Registrars are ACC Ltd. It's auditors are BSR & Co LLP, SR Batliboi & Associates, SR Batliboi & Associates LLP

Latest News